Spexotras
Active substance: trametinib dimethyl sulfoxide
trametinib dimethyl sulfoxide
Centralised EU authorisationActive
Marketing holder: Novartis Europharm Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 5 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-f581-7682-829c-4b4f695f1395,01a12091-67aa-7bf7-bcf1-b8e272a04773,01a12091-6d08-7543-a1b6-31ad2b4108ac,01a12093-4287-7641-8787-01b4f6234e72,01a1209c-e1b6-7801-9f9a-07f4f4b85284;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/005886
- Registration status
- Active
- ATC code
- L01EE01
Sources
- product · EMA · EMEA/H/C/005886 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005886 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005886 · Verified 2026-10-09